arrow
C

Carlo Visco

university of verona
H指数:54
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Role of direct-acting antivirals in people with HIV-associated non-Hodgkin lymphoma and concomitant HCV infection: A study on behalf of the Fondazione Italiana Linfomi

直接抗病毒药物在合并HCV感染的HIV相关非霍奇金淋巴瘤患者中的作用:意大利淋巴瘤基金会研究

2026-09-060
PRE
Pirtobrutinib in Richter syndrome: Outcomes from the named patient programme in Italy

吡柔比星在里奇特综合征中的应用:来自意大利指定患者项目的结果

2026-09-060
OAAI
Application of Hi-C sequencing to detect oncogene rearrangements for diagnosis and treatment of large B-cell lymphoma

Hi-C测序在大型B细胞淋巴瘤的诊断和治疗中检测癌基因重排的应用

2026-06-170
OAAI
Polatuzumab vedotin–containing regimens as bridge to CART: analysis from the CART-SIE study

Polatuzumab vedotin-含方案作为桥接CART:CART-SIE研究分析

2026-05-070
OA
Secondary Genetic Events and Their Relationship to TP53 Mutation in Mantle Cell Lymphoma: A Sub-Study from the FIL_MANTLE-FIRST BIO on Behalf of Fondazione Italiana Linfomi (FIL)

次级遗传事件及其与Mantle Cell Lymphoma中TP53突变的关系:一项来自FIL_MANTLE-FIRST BIO的亚组研究,代表意大利淋巴瘤基金会(FIL)

Cancers
IF4.4
2026-03-040
OAAI
Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosis

活体巨噬细胞和DLBCL细胞中促炎性GSDMD的激活标志着配体相互作用和更好的预后

2025-12-080
OAAI
Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trial

非侵入性基因分型及早期疾病动态变化表明,在TRIANGLE试验中接受治疗的套细胞淋巴瘤患者中,伊布替尼联合免疫化疗的疗效。

Leukemia
IF13.4
2025-11-030
OAAI
Prognostic effects and immune biomarkers associated with gasdermin protein expression in diffuse large B-cell lymphoma
2025-11-010
PRE
Quality and duration of responses with mogamulizumab in cutaneous T-cell lymphomas: Insights into long-lasting outcomes

莫加穆利zumab在皮肤T细胞淋巴瘤中的应答质量和持续时间:对长期结局的见解

2025-09-140
OAAI
Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphoma

预后基因表达和微RNA表达谱特征以及原发性睾丸弥漫性大B细胞淋巴瘤的遗传改变

2025-07-170
PREAI
CAT rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic Leukemia
2024-11-140
OAAI
Neuronal-Glial and Immune Microenvironment Signatures Show Prognostic Effects in Primary CNS Lymphoma

神经元-胶质细胞和免疫微环境特征在原发性中枢神经系统淋巴瘤中显示出预后效应

BLOOD
IF23.1
2024-11-050
PRE
Minimal Residual Disease Evaluation in the Context of V-Rbac, a Risk-Tailored Phase II Trial of the Fondazione Italiana Linfomi (FIL)

V-Rbac背景下微小残留病评估,一项Fondazione Italiana Linfomi (FIL)风险定制II期临床试验

BLOOD
IF23.1
2024-11-050
PRE
Marginal zone lymphoma international prognostic index: a unifying prognostic index for marginal zone lymphomas requiring systemic treatment
2024-06-013
OAAI